Abstract
Background
Triglyceride-glucose (TyG) index, a simple surrogate marker for insulin resistance (IR), has been reported as an independent predictor of arterial structural damage and future cardiovascular events. The association between TyG index and endothelial dysfunction remains uncertain.
Objective
The purpose of this study was to investigate the association between TyG index and endothelial dysfunction.
Methods
Endothelial dysfunction was measured using flow-mediated dilation (FMD). A total of 840 subjects, who voluntarily accepted FMD measurement at the Health Management Department of Xuanwu Hospital from October 2016 to January 2020, were included in this study. TyG index was calculated as Ln [fasting triglyceride (TG)(mg/dL) × fasting plasma glucose (FPG) (mg/dL)/2].
Results
The mean age was 59.92 ± 10.28 years and 559 (66.55%) participants were male. The TyG index was correlated with FMD values (P = 0.022). Each unit increment in TyG index was associated with lower FMD values (β = −0.330, 95%CI −0.609 to −0.052, P = 0.020) after adjusting for covariates. Age (β = −0.069, 95%CI −0.088 to −0.051, P < 0.001), female (β = 0.592, 95%CI 0.172 to1.012, P = 0.006), smoking (β = −0.430, 95%CI −0.859 to −0.002, P = 0.049) and hypertension (β = −0.741, 95%CI −1.117 to −0.365, P < 0.001) were also independent predictors for endothelial dysfunction. A significant association between the TyG index and endothelial dysfunction was found only in populations younger than 60 years (β = −0.843, 95%CI −1.371 to −0.316, P = 0.002), females (β = −0.612, 95%CI −1.147 to −0.077, P = 0.025), and populations without diabetes mellitus (DM) (β = −0.594, 95%CI −1.042 to −0.147, P = 0.009).
Conclusions
Subjects with an elevated TyG index are more likely to have endothelial dysfunction, particularly in populations without DM.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
References
M. Laakso, J. Kuusisto, Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat. Rev. Endocrinol. 10(5), 293–302 (2014)
C. Vlachopoulos et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 112(14), 2193–200 (2005)
A.J. Hanley et al. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 25(7), 1177–84 (2002)
G. Pacini, A. Mari, Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract. Res. Clin. Endocrinol. Metab. 17(3), 305–22 (2003)
L.E. Simental-Mendía, M. Rodríguez-Morán, F. Guerrero-Romero, The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab. Syndr. Relat. Disord. 6(4), 299–304 (2008)
G.L. Vega et al. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and incidence of type 2 diabetes mellitus in men. J. Investig. Med. 62(2), 345–9 (2014)
L. Sánchez-Íñigo et al. The TyG index may predict the development of cardiovascular events. Eur. J. Clin. Investig. 46(2), 189–97 (2016)
M.R. Salazar et al. Comparison of two surrogate estimates of insulin resistance to predict cardiovascular disease in apparently healthy individuals. Nutr. Metab. Cardiovasc. Dis. 27(4), 366–373 (2017)
S. Li et al. The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis. Sci. Rep. 9(1), 7320 (2019)
Q. Zhang et al. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018. Cardiovasc. Diabetol. 22(1), 279 (2023)
A. Yamashina et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens. Res. 26(8), 615–22 (2003)
Y. Matsuzawa et al. Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis. J. Am. Heart. Assoc. 4, 11 (2015)
S. Al-Kindi et al. Relation of coronary calcium scoring with cardiovascular events in patients with diabetes: the CLARIFY registry. J. Diabetes Complic. 36(11), 108269 (2022)
J.J. Cao et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation 116(1), 32–8 (2007)
C. Vlachopoulos, K. Aznaouridis, C. Stefanadis, Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 55(13), 1318–27 (2010)
S. Wu et al. Association between triglyceride-glucose index and risk of arterial stiffness: a cohort study. Cardiovasc. Diabetol. 20(1), 146 (2021)
M. Li et al. Positive association between triglyceride glucose index and arterial stiffness in hypertensive patients: the China H-type Hypertension Registry Study. Cardiovasc. Diabetol. 19(1), 139 (2020)
K.B. Won et al. Relationship of insulin resistance estimated by triglyceride glucose index to arterial stiffness. Lipids Health Dis. 17(1), 268 (2018)
S. Zhao et al. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study. Cardiovasc. Diabetol. 18(1), 95 (2019)
K. Park et al. Elevated TyG index predicts progression of coronary artery calcification. Diabetes Care 42(8), 1569–1573 (2019)
K.B. Won et al. Triglyceride glucose index is an independent predictor for the progression of coronary artery calcification in the absence of heavy coronary artery calcification at baseline. Cardiovasc. Diabetol. 19(1), 34 (2020)
S. Özbiçer, G. Yüksel, Ö. Deniz Urgun, Triglyceride glucose index is independently associated with aortic intima-media thickness in patients without known atherosclerotic cardiovascular disease or diabetes. Diab. Vasc. Dis. Res. 19(5), 14791641221136203 (2022)
D.H.J. Thijssen et al. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans. Eur. Heart J. 40(30), 2534–2547 (2019)
R.M. Bruno et al. Intima media thickness, pulse wave velocity, and flow mediated dilation. Cardiovasc. Ultrasound. 12, 34 (2014)
T. Nakamura et al. Ultrasound assessment of brachial endothelial vasomotor function in addition to carotid plaque echolucency for predicting cardiovascular events in patients with coronary artery disease. Int. J. Cardiol. 167(2), 555–60 (2013)
L. Wang et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc. Diabetol. 19(1), 80 (2020)
F. Guerrero-Romero et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J. Clin. Endocrinol. Metab. 95(7), 3347–51 (2010)
D. Prieto, C. Contreras, A. Sánchez, Endothelial dysfunction, obesity and insulin resistance. Curr. Vasc. Pharmacol. 12(3), 412–26 (2014)
K.E. Bornfeldt, I. Tabas, Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 14(5), 575–85 (2011)
J.D. Symons et al. Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ. Res. 104(9), 1085–94 (2009)
C. Rask-Madsen et al. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab. 11(5), 379–89 (2010)
J.F. Ndisang, A. Vannacci, S. Rastogi, Insulin resistance, type 1 and type 2 diabetes, and related complications 2017. J. Diabetes Res. 2017, 1478294 (2017)
A.M. Chang, J.B. Halter, Aging and insulin secretion. Am. J. Physiol. Endocrinol. Metab. 284(1), E7–12 (2003)
R. Basu et al. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes 52(7), 1738–48 (2003)
Y.S. Levitzky et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J. Am. Coll. Cardiol. 51(3), 264–70 (2008)
Acknowledgements
The authors thank the staff and participants of our study for their important contributions.
Funding
This study was supported by the Program of the National Natural Science Foundation of China (Serial Number: 82170347).
Author information
Authors and Affiliations
Contributions
Y.L., X.C., and J.L. contributed to the conception and design of this article. Y.L., M.Y., and X.Y. drafted and revised the manuscript. Y.L., Y.Z., K.X., J.S., and J.Z. contributed to the case collection and database organization. Y.L., L.S., and H.Z. were responsible for statistical analysis of the data. Y.L., J.S., and Z.L. interpreted the results. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, Y., Yi, M., Wang, X. et al. Association between triglyceride-glucose index and endothelial dysfunction. Endocrine (2024). https://doi.org/10.1007/s12020-024-03785-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12020-024-03785-5